MOHAMMAD FAHAD BIN ASAD MD NPI 1982910527

NPI Details

Mohammad Fahad Bin Asad, MD is a hematology and oncology internal medicine in Peoria, IL with 19 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Mohammad Fahad Bin Asad, MD NPI is 1982910527. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

8940 N WOOD SAGE RD
PEORIA, IL
ZIP 61615-822
Phone: (309) 243-3000
Fax: (309) 243-3274

The NPI 1982910527 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Injection, nivolumab, 1 mg (HCPCS:J9299)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS:J9144)
• Injection, azacitidine, 1 mg (HCPCS:J9025)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, durvalumab, 10 mg (HCPCS:J9173)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg (HCPCS:Q5119)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, potassium chloride, per 2 meq (HCPCS:J3480)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection, iron dextran, 50 mg (HCPCS:J1750)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Magnesium level (HCPCS:83735)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Cyclophosphamide, 100 mg (HCPCS:J9070)
• Injection, pegfilgrastim-apgf, biosimilar, (nyvepria), 0.5 mg (HCPCS:Q5122)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron binding capacity (HCPCS:83550)
• Iron level (HCPCS:83540)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Red blood count, automated test (HCPCS:85045)
• Folic acid level, serum (HCPCS:82746)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Measurement of immunoglobulin light chains (HCPCS:83521)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Injection of drug or substance into vein (HCPCS:96374)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Ct scan of chest with contrast (HCPCS:71260)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
• Uric acid level, blood (HCPCS:84550)
• Protein measurement, serum (HCPCS:84165)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Application of on-body injector for under skin injection (HCPCS:96377)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Stool analysis for blood, by fecal hemoglobin determination by immunoassay (HCPCS:82274)
• Unclassified drugs (HCPCS:J3490)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• Cortisol (hormone) measurement, total (HCPCS:82533)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Electrophoresis, laboratory testing technique (HCPCS:82664)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• X-ray of chest, 2 views (HCPCS:71046)

The enumeration date for this NPI number is 8/20/2010 and was last updated on 10/4/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: